Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy
 For more images, please select "images" in the filters.
In-silico physiological based pharmacokinetic modeling of prodrugs
PDF
A hierarchical physiologically-based pharmacokinetic modeling platform for genetic and exposure effects in metabolic pathways
PDF
Animal to human scaling and pharmacokinetic/pharmacodynamic modeling of anticancer drugs
PDF
Pharmacodynamics and Pharmacokinetics Principles & Roadblocks - A view from the imaging industry, 2007
PDF
Pharmacokinetic/pharmacodynamic modeling for genetically polymorphic populations
PDF
Parametric and non‐parametric modeling of autonomous physiologic systems: applications and multi‐scale modeling of sepsis
PDF
Imaging in Clinical Studies: An Academic Perspective, 2007
PDF
Image-driven pharmacokinetics of tropoelastin nanoparticles
PDF
Nano&Imaging, 2007
PDF
Physiologically-based pharmacokinetics and mechanistically-based pharmacodynamics of geldanamycin derivatives and their application in clinical trials
PDF
Systems pharmacology for acute myeloid leukemia and feedback control pharmacodynamic models
PDF
Comparison of the pharmacokinetic profiles between monomeric and oligomeric transferrin
PDF
Computational model for predicting ionic solubility
PDF
Effects of particle architecture on in-vivo pharmacokinetics and bio-distribution of therapeutic nanostructures
PDF
Nonlinear modeling and machine learning methods for environmental epidemiology
PDF
Noninvasive intratumoral pharmacokinetics of 195mPt-cisplatin validation of model estimates based on subcellular biodistribution studies
PDF
Population modeling and Bayesian estimation for the deconvolution of blood alcohol concentration from transdermal alcohol biosensor data
PDF
Ribavirin systemic and intracellular exposure and its role on viral response and anemia in chronic hepatitis C genotype 1 infection
PDF
The effects of the vitreous state on the ocular pharmacokinetics following intravitreal drug delivery: an evaluation with quantitative magnetic resonance imaging
PDF
Molecular modeling of cyclodextrin interactions with proteins
PDF
The NONMEM approach to estimation of population pharmacokinetic parameters
PDF
Pharmacokinetic/pharmacodynamic analysis of the human growth hormone antagonist Trovert
PDF
Incorporating uncertainty in a physiologically based pharmacokinetic model for dichloromethane risk assessment.
PDF
Analytical and pharmacokinetic studies with Cis-dichlorodiammineplatinum (II) (NSC 119875)
PDF
A user interface for the ADAPT II pharmacokinetic/pharmacodynamic systems analysis software under Windows 2000
PDF
of 2